Advertisement

Polypharmacy in Hypertension

Should Hypertensive Therapy Be Re-evaluated Periodically?
Published:September 11, 2022DOI:https://doi.org/10.1016/j.cger.2022.05.005

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Geriatric Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Whelton P.K.
        • Carey R.M.
        • Aronow W.S.
        • et al.
        2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
        Hypertension. 2018; 71 ([Epub 2017 Nov 13. Erratum in: Hypertension. 2018 Jun;71(6):e136-e139; Erratum in: Hypertension. 2018 Sep;72(3):e33. PMID: 29133354): 1269-1324
        • Aubert C.E.
        • Ha J.K.
        • Kim H.M.
        • et al.
        Clinical outcomes of modifying hypertension treatment intensity in older adults treated to low blood pressure.
        J Am Geriatr Soc. 2021; 69 ([Epub 2021 Jun 7. PMID: 34097300; PMCID: PMC8497391]): 2831-2841
        • James P.A.
        • Oparil S.
        • Carter B.L.
        • et al.
        2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).
        JAMA. 2014; 311 ([Erratum in: JAMA. 2014 May 7;311(17):1809. PMID: 24352797]): 507-520
        • Qaseem A.
        • Wilt T.J.
        • Rich R.
        • et al.
        Clinical guidelines committee of the American College of physicians and the commission on health of the public and science of the American academy of family physicians, Fitterman N, Barry MJ, Horwitch CA, Iorio A, McLean RM. Pharmacologic treatment of hypertension in adults aged 60 Years or older to higher versus lower blood pressure targets: a clinical practice guideline from the American College of physicians and the American academy of family physicians.
        Ann Intern Med. 2017; 166 ([Epub 2017 Jan 17. Erratum in: Ann Intern Med. 2018 Apr 3;168(7):530-532. PMID: 28135725.)]): 430-437https://doi.org/10.7326/M16-1785
        • Wright Jr., J.T.
        • Williamson J.D.
        • Whelton P.K.
        • et al.
        • SPRINT Research Group
        A randomized trial of intensive versus standard blood-pressure control.
        N Engl J Med. 2015; 373 (Nov 9.[Erratum in: N Engl J Med. 2017 Dec 21;377(25):2506. PMID: 26551272; PMCID: PMC4689591]): 2103-2116
        • Unger T.
        • Borghi C.
        • Charchar F.
        • et al.
        2020 International Society of Hypertension global hypertension practice guidelines.
        J Hypertens. 2020; 38 (PMID: 32371787): 982-1004
        • Zhang W.
        • Zhang S.
        • Deng Y.
        • et al.
        • STEP Study Group
        Trial of intensive blood-pressure control in older patients with hypertension.
        N Engl J Med. 2021; 385 (Epub 2021 Aug 30. PMID: 34491661.)): 1268-1279
        • Jaffe M.G.
        • Lee G.A.
        • Young J.D.
        • et al.
        Improved blood pressure control associated with a large-scale hypertension program.
        JAMA. 2013; 310: 699-705
        • Bennett A.
        • Chow C.K.
        • Chou M.
        • et al.
        Efficacy and safety of quarter-dose blood pressure-lowering agents: a systematic review and meta-analysis of randomized controlled trials.
        Hypertension. 2017; 70 (Epub 2017 Jun 5. PMID: 28584013.)): 85-93
        • Calhoun D.A.
        • Lacourcière Y.
        • Chiang Y.T.
        • et al.
        Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial.
        Hypertension. 2009; 54 (Epub 2009 May 26. PMID: 19470877): 32-39
        • Chrysant S.G.
        • Littlejohn 3rd, T.
        • Izzo Jr., J.L.
        • et al.
        Triple-Combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in black and non-black study participants with hypertension: the TRINITY randomized, double-blind, 12-week, parallel-group study.
        Am J Cardiovasc Drugs. 2012; 12: 233-243
        • Jamerson K.
        • Weber M.A.
        • Bakris G.L.
        • et al.
        ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
        N Engl J Med. 2008; 359: 2417-2428
        • Salam A.
        • Kanukula R.
        • Atkins E.
        • et al.
        Efficacy and safety of dual combination therapy of blood pressure-lowering drugs as initial treatment for hypertension: a systematic review and meta-analysis of randomized controlled trials.
        J Hypertens. 2019; 37 (PMID: 30986788): 1768-1774
        • Webster R.
        • Salam A.
        • de Silva H.A.
        • et al.
        • TRIUMPH Study Group
        Fixed low-dose triple combination antihypertensive medication vs usual care for blood pressure control in patients with mild to moderate hypertension in Sri Lanka: a randomized clinical trial.
        JAMA. 2018; 320 ([Erratum in: JAMA. 2018 Nov 13;320(18):1940. PMID: 30120478; PMCID: PMC6583010]): 566-579
        • Finucane T.E.
        • Christmas C.
        • Travis K.
        Tube feeding in patients with advanced dementia: a review of the evidence.
        JAMA. 1999; 282: 1365-1370
        • Gillick M.R.
        Rethinking the role of tube feeding in patients with advanced dementia.
        N Engl J Med. 2000; 342 (PMID: 10639550): 206-210
        • Cai X.
        • Campbell N.
        • Khan B.
        • et al.
        Long-term anticholinergic use and the aging brain.
        Alzheimers Dement. 2013; 9: 377-385
        • Lee S.J.
        • Kim C.M.
        Individualizing prevention for older adults.
        J Am Geriatr Soc. 2018; 66 ([Epub 2017 Nov 20. PMID: 29155445; PMCID: PMC5809295.]): 229-234